Share Consolidation

929 Mainland Street

Vancouver, BC V6B 1S3

Phone

Fax

(604) 928-8913

(604) 628-0129

Email [email protected]

Website www.lexston.ca

NEWS RELEASE

SHARE CONSOLIDATION

Vancouver, British Columbia, May 20, 2022. Lexston Life Sciences Corp. (the “Company”) (CSE: LEXT)

(OTCQB: LEXTF) is providing the following update regarding its common share consolidation announced

on May 13, 2022.

The common shares of the Company will be consolidated on the ratio of five (5) pre-consolidated shares

for one (1) post -consolidated share. Each fractional share remaining after the consolidation that is less

than 1/2 of a share will be cancelled and each fractional share that is at least 1/2 of a share will be changed

to one whole share.

The Company set May 27, 2022 as the record date for the consolidation of its common shares. Trading

on a consolidated basis will start on May 26, 2022.

As a result, the outstanding common shares of the Company will be reduced to approximately

11,746,727 common shares.

The name and the stock symbol of the Company will not change.

The new ISIN of the Company is CA52978A2056 and the new CUSIP is 52978A205.

Letters of transmittal will be mailed to the shareholders of the Company.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913